Innova Partners with Attomarker to Accelerate COVID Immunity Testing
Innova Medical Group formed a strategic partnership with Attomarker to expedite immunity testing for COVID and other diseases globally.
Read MorePosted by Andy Lundin | May 9, 2022 | Company News, Covid 19 |
Innova Medical Group formed a strategic partnership with Attomarker to expedite immunity testing for COVID and other diseases globally.
Read MorePosted by Andy Lundin | May 9, 2022 | Sexually Transmitted Diseases |
Abbott has received FDA clearance for its Alinity m STI Assay, which simultaneously detects and differentiates four common STIs.
Read MorePosted by Andy Lundin | May 5, 2022 | Diagnostic Technologies, Unknown Origin & Other Cancer Types |
Researchers are developing a low-cost handheld device that could cut the rate of unnecessary skin biopsies in half.
Read MorePosted by Chris Wolski | May 4, 2022 | Unknown Origin & Other Cancer Types |
Research indicates that testing an individual’s blood can reveal the presence of circulating melanoma cells, indicating skin cancer.
Read MorePosted by Andy Lundin | May 2, 2022 | Diagnostic Technologies |
A new, accurate method to diagnose bacterial infections has the potential to detect infections in cystic fibrosis patients in minutes.
Read More